Small-molecule-based regulation of RNA-delivered circuits in mammalian cells
- 16 October 2018
- journal article
- research article
- Published by Springer Nature in Nature Chemical Biology
- Vol. 14 (11) , 1043-1050
Abstract
Synthetic mRNA is an attractive vehicle for gene therapies because of its transient nature and improved safety profile over DNA. However, unlike DNA, broadly applicable methods to control expression from mRNA are lacking. Here we describe a platform for small-molecule-based regulation of expression from modified RNA (modRNA) and self-replicating RNA (replicon) delivered to mammalian cells. Specifically, we engineer small-molecule-responsive RNA binding proteins to control expression of proteins from RNA-encoded genetic circuits. Coupled with specific modRNA dosages or engineered elements from a replicon, including a subgenomic promoter library, we demonstrate the capability to externally regulate the timing and level of protein expression. These control mechanisms facilitate the construction of ON, OFF, and two-output switches, with potential therapeutic applications such as inducible cancer immunotherapies. These circuits, along with other synthetic networks that can be developed using these tools, will expand the utility of synthetic mRNA as a therapeutic modality.Keywords
This publication has 42 references indexed in Scilit:
- Intracellular Context Affects Levels of a Chemically Dependent Destabilizing DomainPLOS ONE, 2012
- Small-molecule displacement of a cryptic degron causes conditional protein degradationNature Chemical Biology, 2011
- A Modular Cloning System for Standardized Assembly of Multigene ConstructsPLOS ONE, 2011
- Sequence- and Structure-Specific RNA Processing by a CRISPR EndonucleaseScience, 2010
- A General Chemical Method to Regulate Protein Stability in the Mammalian Central Nervous SystemChemistry & Biology, 2010
- Engineering a Direct and Inducible Protein−RNA Interaction To Regulate RNA BiologyACS Chemical Biology, 2010
- Golden Gate Shuffling: A One-Pot DNA Shuffling Method Based on Type IIs Restriction EnzymesPLOS ONE, 2009
- Incorporation of Pseudouridine Into mRNA Yields Superior Nonimmunogenic Vector With Increased Translational Capacity and Biological StabilityMolecular Therapy, 2008
- A Rapid, Reversible, and Tunable Method to Regulate Protein Function in Living Cells Using Synthetic Small MoleculesCell, 2006
- Suppression of RNA Recognition by Toll-like Receptors: The Impact of Nucleoside Modification and the Evolutionary Origin of RNAImmunity, 2005